Synthetic chemically modified mRNA (modRNA): toward a new technology platform for cardiovascular biology and medicine. - Wikidata - awgldk - TriplyDB

Synthetic chemically modified mRNA (modRNA): toward a new technology platform for cardiovascular biology and medicine.

Synthetic chemically modified mRNA (modRNA): toward a new technology platform for cardiovascular biology and medicine.

http://www.wikidata.org/entity/Q35319305

about

Programming and reprogramming a human heart cell Delivering Nucleic-Acid Based Nanomedicines on Biomaterial Scaffolds for Orthopedic Tissue Repair: Challenges, Progress and Future Perspectives.Gene Transfer to Rodent Hearts In Vivo.Introducing Genes to the Heart: All About Delivery.Design, Assembly, Production, and Transfection of Synthetic Modified mRNA.Genetic Modification of Human Pancreatic Progenitor Cells Through Modified mRNA.Vascular Development and Regeneration in the Mammalian Heart.Optimizing Cardiac Delivery of Modified mRNA.Ablation of a Single N-Glycosylation Site in Human FSTL 1 Induces Cardiomyocyte Proliferation and Cardiac Regeneration Single-Factor SOX2 Mediates Direct Neural Reprogramming of Human Mesenchymal Stem Cells via Transfection of In Vitro Transcribed mRNA

P2860

Q26823933-5FAF7D1B-5B8A-4641-AE94-C01980E569BC Q38912667-A70C73E0-5299-4179-A8D3-DD578EB981F1 Q40445287-2E2187FB-4603-4B09-B639-D7D68B2E9BC4 Q45863402-018FD335-1B50-4C8A-A20B-5B28E6E0A98F Q45873696-DDE1BEA4-319B-4B0A-8AFF-EC7F4451F0B6 Q45887525-FDED4F74-0986-4EA8-8F45-6506BBBDC74B Q48678269-9311F67B-E892-4E25-80F2-6EA204442B57 Q50445673-9174496E-04EF-4037-92FC-C699B015CACF Q57128494-B1489AD0-88C6-4835-B50D-14A7869A612E Q57177827-CBD5F044-9884-4F1C-BCBA-A6A43924C3AB

P2860

Synthetic chemically modified mRNA (modRNA): toward a new technology platform for cardiovascular biology and medicine.

http://www.wikidata.org/entity/Q35319305

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Synthetic chemically modified ...... vascular biology and medicine.

@ast

Synthetic chemically modified ...... vascular biology and medicine.

@en

type

label

Synthetic chemically modified ...... vascular biology and medicine.

@ast

Synthetic chemically modified ...... vascular biology and medicine.

@en

prefLabel

Synthetic chemically modified ...... vascular biology and medicine.

@ast

Synthetic chemically modified ...... vascular biology and medicine.

@en

P1433

Q35319305-1DA30D0F-6762-48E2-A578-051A0723B788

P1476

Q35319305-9C1B00E9-1ED1-4C43-BEC5-606B8CB385E2

P2093

Q35319305-64284361-AA03-4196-8464-F1D59A13D218

Q35319305-F70D27A6-849C-4C14-9A3C-1941B81931AE

P2860

Q35319305-04116B67-34E2-4CD4-82A9-9B521B653D65

Q35319305-0B78797E-45DC-4C9C-ACA9-868B5916B084

Q35319305-0BF1840D-8643-4B8C-8E52-AB936EFB8C10

Q35319305-26309F5B-ACD7-4F56-BC34-E9F827EAAE51

Q35319305-265BFA5E-D97F-41F1-8CFD-7D38D18F27C9

Q35319305-2A798291-C6C0-430F-A9A8-2EB1A6EDEC37

Q35319305-2F0E1EC2-48EF-4C96-A0CA-A3283C2E88AA

Q35319305-34415DAB-FE00-4C25-BE3E-9937F9FA84D5

Q35319305-3F15CF59-2727-453A-B3C2-CBF7FAC6DC86

Q35319305-401DA154-23FC-46C1-A386-8AA7B05BF64C

P304

Q35319305-434C65BF-3A6E-417F-BF61-346CDCB541FE

P31

Q35319305-D686B19C-EC4E-497F-905A-4C0AE7FAAB17

P356

Q35319305-E464F375-12A9-4DC6-AA38-7BE330412A53

P433

Q35319305-3E55E27E-3CAE-4915-A91D-4AE298539975

P478

Q35319305-1080DD4D-C0A5-41EC-BD07-B69446262AEB

P50

Q35319305-5B862B57-EF98-47DE-8EEA-5B19368510F2

P577

Q35319305-563ADCC9-D981-4D5A-A2CB-C3DE454062C9

P5875

Q35319305-21309228-B6B6-4BC2-B40E-DE1A8C466ED6

P698

Q35319305-FFAD9B63-3ABD-4A4F-84C6-037796888DBA

P932

Q35319305-D5E6FA19-E96C-425A-A163-F21AC189F81B

P356

CSHPERSPECT.A014035

P1433

Cold Spring Harbor Perspectives in Medicine

P1476

Synthetic chemically modified ...... vascular biology and medicine.

@en

P2093

Kenneth R Chien

http://www.w3.org/2001/XMLSchema#string

Lior Zangi

http://www.w3.org/2001/XMLSchema#string

P2860

Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA

Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

Adeno-associated virus vectors as therapeutic and investigational tools in the cardiovascular system

Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188

mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts

Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial

Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial

Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction

Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia.

P304

a014035

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1101/CSHPERSPECT.A014035

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266744174

http://www.w3.org/2001/XMLSchema#string

P698

25301935

http://www.w3.org/2001/XMLSchema#string

P932

4292072

http://www.w3.org/2001/XMLSchema#string